Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA3 | P07451 | 1/20 | 0.32 |
| ▸ | CA4 | P22748 | 1/20 | 0.32 |
| ▸ | CA6 | P23280 | 1/20 | 0.32 |
| ▸ | CA5A | P35218 | 1/20 | 0.32 |
| ▸ | CA7 | P43166 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.32 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19854371 | 1.00 | LMNA (0.32) | LMNACA12CA1CA2CA3 | |
| SCHEMBL21034522 | 0.87 | LMNA (0.31) | LMNACA12CA1CA2CA3 | |
| SCHEMBL19854882 | 0.87 | LMNA (0.34) | LMNACA12CA1CA2CA3 | |
| SCHEMBL19854373 | 0.87 | LMNA (0.34) | LMNACA12CA1CA2CA3 | |
| SCHEMBL19839445 | 0.85 | LMNA (0.36) | LMNACA12CA1CA2CA3 | |
| SCHEMBL21034806 | 0.85 | LMNA (0.36) | LMNACA12CA1CA2CA3 | |
| SCHEMBL19854879 | 0.85 | LMNA (0.36) | LMNACA12CA1CA2CA3 | |
| SCHEMBL19853784 | 0.85 | EP300 (0.33) | LMNACA12CA1CA2CA3 | |
| SCHEMBL19853736 | 0.81 | ALOX15 (0.34) | LMNACA12CA1CA2CA3 | |
| SCHEMBL23153058 | 0.80 | OPRK1 (0.33) | LMNACA12CA1CA2CA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018026763-A1 | SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND USES THEREOF | APTINYX INC. (US) | 2018-02-08 | — | — | WO | disclosed |